Aim & Scope
Annals of Nanomedicine and Nanotechnology (ANN) is a peer-reviewed, open-access journal published by Somato Publications. It publishes research on nanoscale materials and their use in diagnosis, drug delivery and therapy.
We welcome work that is careful about characterisation, safety and reproducibility as well as performance.
Scope
ANN publishes original research articles, review articles, case reports and short communications in areas including, but not limited to:
- Nanoparticle drug delivery
- Nanodiagnostics and biosensors
- Nanomaterials synthesis and characterisation
- Theranostics
- Nanotoxicology and safety
- Nanotechnology in imaging
- Tissue engineering and nanobiomaterials
- Regulatory and translational aspects
Peer Review
Every submission goes through double-blind peer review by at least two independent reviewers with expertise in the subject. The usual time from submission to first editorial decision is 12–14 weeks. See the Peer Review Policy for details.
Originality
All manuscripts are screened for similarity with iThenticate before they go to reviewers, as set out in the Plagiarism Policy.
Open Access and Licensing
ANN is fully open access. Authors keep the copyright in their work, which is published under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Article Processing Charges
There is no Article Processing Charge. Annals of Nanomedicine and Nanotechnology charges authors nothing at any stage of submission, peer review or publication.
